Pioneering the Future of Biological Innovation
XENTHYA is revolutionizing healthcare through cutting-edge biotechnology solutions that bridge the gap between research and real-world applications.
XENTHYA is revolutionizing healthcare through cutting-edge biotechnology solutions that bridge the gap between research and real-world applications.
At XENTHYA, we combine cutting-edge biotechnology with artificial intelligence to develop novel therapeutic solutions.
Developing targeted therapies tailored to individual genetic profiles for more effective treatment.
Harnessing machine learning to accelerate drug discovery and reduce development timelines.
Pioneering gene editing techniques to treat genetic disorders at their root cause.
Founded in 2025, XENTHYA was established with the vision to revolutionize healthcare through biotechnology. Our team of world-class scientists and researchers are dedicated to pushing the boundaries of what's possible in medicine.
We collaborate with leading academic institutions, pharmaceutical companies, and healthcare providers to accelerate the development of life-saving therapies and make them accessible to those in need.
Addressing the most pressing healthcare challenges with innovative biotechnological approaches.
Novel broad-spectrum antiviral compounds with high efficacy and low resistance potential.
Learn MoreNext-generation CAR-T cell therapies with enhanced specificity and reduced side effects.
Learn MoreCRISPR-based treatments for monogenic disorders with permanent therapeutic effects.
Learn MoreTargeted modulation of gut microbiota to treat metabolic and autoimmune conditions.
Learn MoreNovel protein-targeting therapies for Alzheimer's and Parkinson's disease.
Learn MoreCombining multiple cutting-edge technologies to accelerate discovery and development.
Our proprietary machine learning algorithms analyze billions of molecular interactions to identify promising therapeutic candidates with unprecedented speed and accuracy.
Automated robotic systems test millions of compounds against disease targets, generating massive datasets that feed our AI models.
State-of-the-art cryogenic electron microscopy allows us to visualize molecular structures at near-atomic resolution, enabling precise drug design.
Our technology platform creates a virtuous cycle where each component enhances the others, dramatically reducing the time and cost of bringing new therapies to patients.
Whether you're interested in collaborating, investing, or learning more about our technologies, we'd love to hear from you.
Have questions about our technology or interested in collaboration opportunities? Reach out to our team.
Foundation for Research and Technology - Hellas Ν. Plastira 100, Vassilika Vouton GR - 700 13, Heraklion, Crete
info@xenthya.com
(+30) 281-XXXXX